Definitions

Sorry, no definitions found. You may find more data at dacogen.

Etymologies

Sorry, no etymologies found.

Support

Help support Wordnik (and make this page ad-free) by adopting the word Dacogen.

Examples

  • This has allowed products such as Dacogen (decitabine), a novel treatment for myelodysplastic syndrome produced by Johnson

    PharmaTimes World News 2010

  • This has allowed products such as Dacogen (decitabine), a novel treatment for myelodysplastic syndrome produced by Johnson & Johnson's Xian-Janssen unit, to be marketed in China based on clinical trials conducted overseas because the condition represents an unmet medical need in the country and the patient population there is small.

    PharmaTimes World News 2010

  • This has allowed products such as Dacogen (decitabine), a novel treatment for myelodysplastic syndrome produced by Johnson

    PharmaTimes World News 2010

  • In a brochure given to doctors and nurses last year, the Japanese drug company Eisai claimed that its Dacogen drug helped 38% of patients with a rare blood cell disorder in a clinical study.

    Ten Misleading Drug Ads 2010

  • Dacogen did not achieve statistically significant superiority over the control arm.

    Acuity Brands Ups Sales, But Profits Dip 2010

  • In a brochure given to doctors and nurses last year, the Japanese drug company Eisai claimed that its Dacogen drug helped 38% of patients with a rare blood cell disorder in a clinical study.

    Ten Misleading Drug Ads Rebecca Ruiz 2010

  • The licensing agreement covers exclusive development and commercialization rights for Dacogen and applies to all territory outside North America.

    Three Deals Head Slow Biotech Week 2006

  • Dacogen was approved in May by the U.S. Food and Drug Administration as a treatment for myelodysplastic syndromes MDS, which occur when defective stem cells produce too few or poorly functioning blood cells.

    Three Deals Head Slow Biotech Week 2006

  • MGI Pharma and its partner, SuperGen, announced on Thursday that they have licensed their blood-disorder treatment, Dacogen, to Johnson and Johnson unit Cilag.

    Three Deals Head Slow Biotech Week 2006

  • Dacogen is already approved to treat myelodysplastic syndromes -- a group of diseases in which the production of blood cells by the bone marrow is disrupted.

    Yahoo! News: Business - Opinion 2012

Comments

Log in or sign up to get involved in the conversation. It's quick and easy.